跳至主要内容
临床试验/NCT00419055
NCT00419055终止不适用

Outpatient Percutaneous Coronary Intervention in a Selected, Stable Patient Population

University of Pennsylvania0 个研究点目标入组 100 人开始时间: 2004年8月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
100
主要终点
The primary endpoints are patient satisfaction and safety.

研究概览

简要总结

To determine the safety and feasibility of same day discharge after elective coronary percutaneous intervention in a selected stable patient population. The hypothesis to be tested is that in an appropriately selected stable coronary artery disease population post percutaneous coronary intervention, early discharge is safe and feasible.

详细描述

A select stable population of patients undergoing percutaneous coronary intervention are randomized to standard of care in-hospital stay for one night or early discharge to a nearby hotel. During PCI, patients receive bivalirudin as their anti-coagulant and also must be eligible for an angioseal closure device. Patients that stay overnight in the hotel must be accompanied by a family member. They return to the cath lab the next day for groin check and blood work. Satisfaction questionnaires are filled out by all patients.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with stable coronary artery disease scheduled for elective percutaneous coronary intervention

排除标准

  • Patients with acute coronary syndrome, patients with an MI within 30 days, an ejection fraction <30%, those with history of IV Dye allergy, creatinine level>2.2, those with increased risk of infection, those with history of bleeding diathesis or anemia (hemoglobin<11.0 g/dl, platelets <100,000 tho/ul)

结局指标

主要结局

The primary endpoints are patient satisfaction and safety.

时间窗: 30 days

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验